20 stories about Cancer
מנכ"לית קומפיוג'ן ד"ר ענת כהן דייג

Compugen shares soar on massive deal with Gilead, worth up to $848 million

19.12.23|Sophie Shulman
The Israeli company utilizes its broadly applicable predictive computational discovery capabilities to identify new drug targets and biological pathways for developing novel cancer immunotherapies
 מייסדי אייבקס, מימין: ד"ר חיים לינהרט ויוסי מוסל

Ibex Medical raises $55 million Series C for AI-powered cancer diagnostics

06.09.23|Meir Orbach
The Israeli startup’s platform provides health systems and diagnostic laboratories with an integrated solution for cancer diagnosis and biomarker scoring, capable of detecting more than 100 different cancer and non-cancer pathologies
צוות Nectin Therapeutics

Nectin Therapeutics raises $25 million Series A to treat advanced cancer tumors

30.11.22|Meir Orbach
The Israeli company is aiming to achieve new standards for efficacy and patient response across a number of difficult-to-treat cancers
Itay Barnea BioProtect

Is it time to reconsider PSA tests for Prostate Cancer?

01.09.22|Itay Barnea
“The treating physician should determine what is best for the patient based on his unique age, family history, health, lifestyle, race, ethnic background, and other factors,” writes Itay Barnea, CEO of BioProtect
Dr. Ofer Sharon - OncoHost CEO

Collaboration is the key to advancing cancer care

30.08.22|Ofer Sharon
Israel can become a precision oncology powerhouse, but we need to change direction, writes Dr. Ofer Sharon, CEO of OncoHost
Spotitearly team

SpotitEarly raises $6.2 million for early detection of cancers based on olfactory abilities of dogs

Each type of cancer has a unique odor, and most also have a common denominator. Dogs can detect these odors in a fraction of a second
מייסדי Imagene AI. מימין: יהונתן צלח, דין ביתן, שחר פורת והמדענית הראשית ד"ר נורית פז

Larry Ellison leads $21.5 million Series A in cancer treatment startup Imagene AI

02.05.22|Meir Orbach
Using only a digitized biopsy image, the Israeli startup’s diagnostic technology delivers real-time molecular analysis, increasing the level of accuracy and reducing the time required for results, from several weeks to just two minutes
מוסף שבועי 9.12.21 ד"ר ארנה ברי

“I still feel like Cinderella and that I’m here by mistake”

16.04.22|Diana Bahur-Nir
After beating multiple cancers, former Chief Scientist Orna Berry turned being a cancer survivor into a hobby
מעבדה רפואה 1 זירת הבריאות

Nucleix announces $22 million in funding, advancements in lung cancer detection program

05.01.22|Meir Orbach
The Israeli company develops non-invasive, DNA methylation-based cancer screening tests for early-stage and recurring cancer detection
יחזקאל ברנהולץ Ayana Pharma

Israeli companies send nanotechnology cancer treatment experiment to space aboard SpaceX

The drug, developed in Israel by Ayana Pharma, will be tested under zero-gravity conditions after being launched last week in a smart laboratory belonging to Israeli company SpacePharma aboard Elon Musk's Falcon 9 launcher
ירון פרג מנכל כאהר מדיקל

KAHR announced $46.5 million funding round to advance its immunotherapeutic pipeline

16.06.21|James Spiro
The round will be used to advance the clinical development of KAHR’s lead product candidate, DSP107
Joseph Mossel

Ibex Medical Analytics granted ‘Breakthrough Device Designation’ by the FDA, fast-tracking its approval

09.06.21|James Spiro
The U.S Food and Drug Administration formally acknowledged its Galen platform and the potential benefit it has on American patients
IBEX CE approved

Ibex obtains CE Mark for AI-powered breast cancer detection

26.05.21|James Spiro
The Ibex Galen Breast solution can detect multiple types of breast cancer and provide accurate diagnoses
אייסקיור הליך הקפאת גידול בשד

Israel’s IceCure granted FDA Breakthrough Medical Device designation

04.04.21|Hezi Sternlicht
The decision puts the company’s tumor-freezing technology on the fast track for final approval
Joseph Mossel

Ibex Medical Analytics raises $38 million for AI-powered cancer diagnostics solutions

09.03.21|Meir Orbach
Ibex’s solutions detect cancer in real-time, enabling 100% quality control, while also reducing turnaround times
קרן אמון מימין ד"ר תומר ברקוביץ ד"ר יאיר שינדל טוד סון איציק דבש

Israel’s aMoon fund saw a 15-fold return on its investment in Seer

09.12.20|Sophie Shulman
aMoon invested in the U.S. biomed company when it was valued at $228 million- after a Nasdaq IPO, its value ballooned to $3.5 billion
ביופסיה לימקה מדיקל 2

Limaca Medical raises $1.25 million for precision biopsy device

11.11.20|Yafit Ovadia
The medical device company’s solution refines ultrasound-guided biopsies to improve tumor detection and other cancer diagnoses
מימין תומר קריב ו רן נוסבאום מנהלי קרן פונטיפקס

Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold

12.10.20|Tzally Greenberg
A series of successful exits and investments see the Israeli fund balloon by 22% to hit $404 million since the start of the Covid-19 crisis
Joseph Mossel

Israel’s Ibex Medical Analytics Deploys in Puerto Rico, establishing a foothold in the Americas

01.09.20|James Spiro
Its Galen Prostate solution helps pathologists with more accurate diagnoses and improves lab efficiency
מוסף שבועי 6.8.20 אנשי חברת שיגור הלוויינים אריאן ליד הטיל שצוייד בלוויין של ספייס פארמה יוני 2020

The cure is out there: Miniature space labs are leading to scientific breakthroughs

08.08.20|Yoghev Carmel
From attempts to crack the aging process to developing asthma medicine, the most innovative medical experiments are taking place these days in space